OPK Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
163.6M
+31.7%
124.2M
-16.3%
148.4M
-2.1%
151.7M
-3.3%
156.8M
Cost of Revenue
83.6M
+6.5%
78.4M
-7.1%
84.4M
-17.0%
101.8M
-5.2%
107.4M
Gross Profit
80.0M
+74.9%
45.8M
-28.5%
64.0M
+28.3%
49.9M
+1.0%
49.4M
Operating Expenses
105.1M
+8.6%
96.8M
-5.4%
102.3M
-1.0%
103.4M
-5.5%
109.4M
R&D
33.2M
+13.6%
29.2M
-10.9%
32.8M
+9.0%
30.1M
-0.9%
30.3M
SG&A
52.9M
+8.9%
48.6M
-3.8%
50.5M
-6.1%
53.8M
-9.7%
59.6M
Operating Income
-25042000
+50.9%
-51017000
-33.1%
-38317000
+28.4%
-53520000
+10.8%
-59981000
EBITDA
-2634000
+90.9%
-28816000
-80.7%
-15944000
+48.2%
-30780000
+16.7%
-36954000
Net Income
-8416000
+84.7%
-54848000
-75.5%
-31257000
-244.5%
21.6M
+114.6%
-148441000
EPS (Basic)
$-0.01
+85.7%
$-0.07
-75.0%
$-0.04
-233.3%
$0.03
+115.8%
$-0.19
EPS (Diluted)
$-0.01
+85.7%
$-0.07
-75.0%
$-0.04
-233.3%
$0.03
+115.8%
$-0.19
Shares (Diluted)
755.3M
-0.5%
758.9M
-0.8%
765.0M
-1.9%
779.9M
-1.0%
788.0M
Opko Health (OPK) โ€” Financials